Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity	NANOGP8 NANOG	1.28e-04	4	93	2	GO:0001010
GeneOntologyMolecularFunction	ubiquitin-protein transferase activity	HECTD4 DZIP3 TRIM31 KLHL42 BIRC2 HERC6 BCOR FBXL5 TRIM7	3.60e-04	473	93	9	GO:0004842
GeneOntologyMolecularFunction	calcium ion sensor activity	MICU3 EFHB	4.44e-04	7	93	2	GO:0061891
GeneOntologyMolecularFunction	metal ion sensor activity	MICU3 EFHB	5.90e-04	8	93	2	GO:0140784
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	HECTD4 DZIP3 TRIM31 KLHL42 BIRC2 HERC6 BCOR FBXL5 TRIM7	6.37e-04	512	93	9	GO:0019787
GeneOntologyMolecularFunction	aminoacyltransferase activity	HECTD4 DZIP3 TRIM31 KLHL42 BIRC2 HERC6 BCOR FBXL5 TRIM7	8.36e-04	532	93	9	GO:0016755
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	HOXB3 NANOGP8 ZBED4 NANOG EHF ELK1 ELK3 TBX1 TLX1	1.20e-03	560	93	9	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	HOXB3 NANOGP8 ZBED4 NANOG EHF ELK1 ELK3 TBX1 TLX1	1.29e-03	566	93	9	GO:0001216
GeneOntologyBiologicalProcess	negative regulation of protein-containing complex assembly	CSNK1A1L CSNK1A1 AVIL CAPZA1 CAPZA2 TRIM31 BIRC2 INPP5J	1.06e-06	173	92	8	GO:0031333
GeneOntologyBiologicalProcess	cranial nerve morphogenesis	HOXA3 HOXB3 DMD TBX1	1.21e-05	32	92	4	GO:0021602
GeneOntologyBiologicalProcess	negative regulation of NLRP3 inflammasome complex assembly	CSNK1A1L CSNK1A1 TRIM31	7.90e-05	19	92	3	GO:1900226
GeneOntologyBiologicalProcess	negative regulation of inflammasome-mediated signaling pathway	CSNK1A1L CSNK1A1 TRIM31	1.08e-04	21	92	3	GO:0141086
GeneOntologyBiologicalProcess	glossopharyngeal nerve morphogenesis	HOXA3 HOXB3	1.17e-04	4	92	2	GO:0021615
GeneOntologyBiologicalProcess	negative regulation of endodermal cell fate specification	NANOGP8 NANOG	1.17e-04	4	92	2	GO:0042664
GeneOntologyBiologicalProcess	glossopharyngeal nerve development	HOXA3 HOXB3	1.95e-04	5	92	2	GO:0021563
GeneOntologyBiologicalProcess	regulation of endodermal cell fate specification	NANOGP8 NANOG	1.95e-04	5	92	2	GO:0042663
GeneOntologyBiologicalProcess	cranial nerve development	HOXA3 HOXB3 DMD TBX1	2.29e-04	67	92	4	GO:0021545
GeneOntologyBiologicalProcess	barbed-end actin filament capping	AVIL CAPZA1 CAPZA2	2.88e-04	29	92	3	GO:0051016
GeneOntologyBiologicalProcess	negative regulation of endodermal cell differentiation	NANOGP8 NANOG	2.92e-04	6	92	2	GO:1903225
GeneOntologyBiologicalProcess	regulation of protein-containing complex assembly	CSNK1A1L ATR CSNK1A1 AVIL CAPZA1 CAPZA2 TRIM31 BIRC2 INPP5J	3.34e-04	489	92	9	GO:0043254
MousePheno	fusion of glossopharyngeal and vagus nerve	HOXA3 HOXB3 TBX1	2.37e-05	11	75	3	MP:0004568
Domain	F_ACTIN_CAPPING_A_1	CAPZA1 CAPZA2	6.72e-05	3	89	2	PS00748
Domain	F_ACTIN_CAPPING_A_2	CAPZA1 CAPZA2	6.72e-05	3	89	2	PS00749
Domain	F-actin_cap_A	CAPZA1 CAPZA2	6.72e-05	3	89	2	PF01267
Domain	CapZ_alpha	CAPZA1 CAPZA2	6.72e-05	3	89	2	IPR002189
Domain	DUF4074	HOXA3 HOXB3	6.72e-05	3	89	2	IPR025281
Domain	F-actin_cap_asu_CS	CAPZA1 CAPZA2	6.72e-05	3	89	2	IPR017865
Domain	DUF4074	HOXA3 HOXB3	6.72e-05	3	89	2	PF13293
Domain	Homeobox	HOXA3 HOXB3 NANOGP8 ZEB1 NANOG TLX3 TLX1	1.28e-04	234	89	7	PF00046
Domain	Znf_B-box_chordata	TRIM31 TRIM7	1.34e-04	4	89	2	IPR020457
Domain	HOMEOBOX_1	HOXA3 HOXB3 NANOGP8 ZEB1 NANOG TLX3 TLX1	1.35e-04	236	89	7	PS00027
Domain	HOX	HOXA3 HOXB3 NANOGP8 ZEB1 NANOG TLX3 TLX1	1.38e-04	237	89	7	SM00389
Domain	HOMEOBOX_2	HOXA3 HOXB3 NANOGP8 ZEB1 NANOG TLX3 TLX1	1.45e-04	239	89	7	PS50071
Domain	Homeobox_dom	HOXA3 HOXB3 NANOGP8 ZEB1 NANOG TLX3 TLX1	1.45e-04	239	89	7	IPR001356
Domain	ETS_DOMAIN_1	EHF ELK1 ELK3	3.14e-04	28	89	3	PS00345
Domain	ETS_DOMAIN_2	EHF ELK1 ELK3	3.14e-04	28	89	3	PS00346
Domain	ETS	EHF ELK1 ELK3	3.14e-04	28	89	3	SM00413
Domain	Ets_dom	EHF ELK1 ELK3	3.14e-04	28	89	3	IPR000418
Domain	ETS_DOMAIN_3	EHF ELK1 ELK3	3.14e-04	28	89	3	PS50061
Domain	Ets	EHF ELK1 ELK3	3.14e-04	28	89	3	PF00178
Domain	Homeobox_metazoa	HOXA3 HOXB3 TLX3 TLX1	9.01e-04	90	89	4	IPR020479
Domain	Homeodomain-like	HOXA3 HOXB3 NANOGP8 ZEB1 NANOG TLX3 TLX1	1.04e-03	332	89	7	IPR009057
Domain	EF_Hand_1_Ca_BS	MICU3 ITSN2 PPEF2 EFHB DNAH7	1.50e-03	175	89	5	IPR018247
Domain	HEAT	PPP2R1B ATR ECPAS	1.55e-03	48	89	3	PF02985
Domain	Homeobox_CS	HOXA3 HOXB3 NANOG TLX3 TLX1	1.96e-03	186	89	5	IPR017970
Domain	Dynein_heavy_chain_D4_dom	DNAH7 DNAH1	1.97e-03	14	89	2	IPR024317
Domain	Dynein_HC_stalk	DNAH7 DNAH1	1.97e-03	14	89	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH7 DNAH1	1.97e-03	14	89	2	IPR013602
Domain	DHC_N2	DNAH7 DNAH1	1.97e-03	14	89	2	PF08393
Domain	MT	DNAH7 DNAH1	1.97e-03	14	89	2	PF12777
Domain	AAA_8	DNAH7 DNAH1	1.97e-03	14	89	2	PF12780
Domain	DHC_fam	DNAH7 DNAH1	2.26e-03	15	89	2	IPR026983
Domain	Dynein_heavy_dom	DNAH7 DNAH1	2.26e-03	15	89	2	IPR004273
Domain	Dynein_heavy	DNAH7 DNAH1	2.26e-03	15	89	2	PF03028
Domain	-	HOXA3 HOXB3 ZEB1 NANOG TLX3 TLX1	2.33e-03	283	89	6	1.10.10.60
Domain	HEAT	PPP2R1B ATR ECPAS	2.67e-03	58	89	3	IPR000357
Domain	HEAT_type_2	PPP2R1B ATR	2.91e-03	17	89	2	IPR021133
Domain	Homeobox_Antennapedia_CS	HOXA3 HOXB3	4.45e-03	21	89	2	IPR001827
Domain	HEAT_REPEAT	PPP2R1B ATR ECPAS	4.55e-03	70	89	3	PS50077
Domain	EF_hand_dom	MICU3 ITSN2 PPEF2 EFHB DNAH7	5.05e-03	232	89	5	IPR002048
Domain	TPR-like_helical_dom	TMTC3 ATR IFT172 ZFC3H1 PPID	5.14e-03	233	89	5	IPR011990
Domain	Keratin_2_head	KRT8 KRT82	5.79e-03	24	89	2	IPR032444
Domain	ANTENNAPEDIA	HOXA3 HOXB3	5.79e-03	24	89	2	PS00032
Domain	Keratin_2_head	KRT8 KRT82	5.79e-03	24	89	2	PF16208
Domain	EF-hand_1	MICU3 ITSN2 PPEF2 EFHB	6.03e-03	152	89	4	PF00036
Domain	Keratin_II	KRT8 KRT82	6.77e-03	26	89	2	IPR003054
Domain	EFh	MICU3 ITSN2 PPEF2 EFHB	6.90e-03	158	89	4	SM00054
Domain	TPR_REGION	TMTC3 IFT172 ZFC3H1 PPID	8.01e-03	165	89	4	PS50293
Domain	TPR	TMTC3 IFT172 ZFC3H1 PPID	8.01e-03	165	89	4	PS50005
Domain	-	MICU3 ITSN2 DMD PPEF2 EFHB	8.21e-03	261	89	5	1.10.238.10
Pathway	WP_ID_SIGNALING	RBL2 ELK1 ELK3	3.75e-05	16	59	3	M39359
Pathway	REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE	PPP2R1B CSNK1A1L CSNK1A1	5.43e-05	18	59	3	MM14759
Pubmed	An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.	NANOGP8 CSNK1A1L CSNK1A1 NANOG ELK1 ELK3	3.94e-10	33	96	6	30783098
Pubmed	Hox cofactors in vertebrate development.	HOXA3 HOXB3 TLX3 TLX1	1.13e-08	10	96	4	16515781
Pubmed	Establishment of totipotency does not depend on Oct4A.	KRT8 NANOGP8 NANOG TBX1	2.55e-07	20	96	4	23934214
Pubmed	Maternal Cdx2 is dispensable for mouse development.	KRT8 NANOGP8 NANOG	4.05e-07	6	96	3	22992952
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MIX23 KRT8 ZBED4 HSPA4L CEBPZ AVIL ITSN2 CAPZA1 CAPZA2 CFAP45 DLEC1 ZFC3H1 DMD CCDC77 STK31 TBX1	2.03e-06	1442	96	16	35575683
Pubmed	Ectopic expression of GATA6 bypasses requirement for Grb2 in primitive endoderm formation.	KRT8 NANOGP8 NANOG	2.41e-06	10	96	3	20925113
Pubmed	Tlx3 and Tlx1 are post-mitotic selector genes determining glutamatergic over GABAergic cell fates.	TLX3 TBX1 TLX1	3.31e-06	11	96	3	15064766
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PPP1R2 KRT8 ODF2L CSNK1A1 CEP290 ITSN2 CAPZA1 CCDC77 ECPAS PPID DNAH7 TXLNG	4.16e-06	853	96	12	28718761
Pubmed	TEAD4 regulates KRT8 and YAP in preimplantation embryos in mice but not in cattle.	KRT8 NANOGP8 NANOG	7.26e-06	14	96	3	38206180
Pubmed	Keratins are asymmetrically inherited fate determinants in the mammalian embryo.	KRT8 NANOGP8 NANOG	7.26e-06	14	96	3	32848249
Pubmed	Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	23354688
Pubmed	Independent regulation of initiation and maintenance phases of Hoxa3 expression in the vertebrate hindbrain involve auto- and cross-regulatory mechanisms.	HOXA3 HOXB3	7.54e-06	2	96	2	11566863
Pubmed	Tissue-specific distribution of mouse casein kinase I alpha mRNA.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	9522121
Pubmed	Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	25994086
Pubmed	CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	37723657
Pubmed	Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	36929849
Pubmed	ZEB1 protects skeletal muscle from damage and is required for its regeneration.	ZEB1 DMD	7.54e-06	2	96	2	30910999
Pubmed	Functional evidence that the self-renewal gene NANOG regulates human tumor development.	NANOGP8 NANOG	7.54e-06	2	96	2	19415763
Pubmed	Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.	NANOGP8 NANOG	7.54e-06	2	96	2	24598770
Pubmed	Class III β-Tubulin Expression Is of Value in Selecting nab -Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	35695793
Pubmed	Differential expression of nanog1 and nanogp8 in colon cancer cells.	NANOGP8 NANOG	7.54e-06	2	96	2	22079639
Pubmed	Exploring the role of casein kinase 1α splice variants across cancer cell lines.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	38852281
Pubmed	ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells.	ZEB1 ELK3	7.54e-06	2	96	2	31511359
Pubmed	Casein kinase 1 alpha regulates chromosome congression and separation during mouse oocyte meiotic maturation and early embryo development.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	23690993
Pubmed	Zeb1 affects epithelial cell adhesion by diverting glycosphingolipid metabolism.	ZEB1 ST3GAL5	7.54e-06	2	96	2	25643708
Pubmed	Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	34216174
Pubmed	Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	37108197
Pubmed	Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.	ELK1 ELK3	7.54e-06	2	96	2	29892795
Pubmed	Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.	TLX3 TLX1	7.54e-06	2	96	2	18368072
Pubmed	Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice.	CSNK1A1L CSNK1A1	7.54e-06	2	96	2	36542875
Pubmed	Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.	NANOGP8 NANOG	7.54e-06	2	96	2	21136380
Pubmed	A census of human transcription factors: function, expression and evolution.	HOXA3 HOXB3 ZEB1 ZBED4 CEBPZ NANOG EHF TLX3 ELK1 ELK3 TBX1 TLX1	7.81e-06	908	96	12	19274049
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	HOXA3 HOXB3 KRT8 NANOGP8 NANOG ELK1 ELK3	8.77e-06	263	96	7	20932939
Pubmed	Contribution of Hox genes to the diversity of the hindbrain sensory system.	HOXA3 HOXB3 TLX3	1.35e-05	17	96	3	14960494
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	GGH ZEB1 HSPA4L RBL2 ELK1 BCOR PPID PACSIN2	1.51e-05	398	96	8	35016035
Pubmed	Notch and Hippo signaling converge on Strawberry Notch 1 (Sbno1) to synergistically activate Cdx2 during specification of the trophectoderm.	KRT8 NANOGP8 NANOG	1.61e-05	18	96	3	28401892
Pubmed	The Numb/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells.	NANOGP8 ZEB1 NANOG	1.61e-05	18	96	3	26598619
Pubmed	Murine inner cell mass-derived lineages depend on Sall4 function.	KRT8 NANOGP8 NANOG	1.61e-05	18	96	3	17060609
Pubmed	Multiple roles for HOXA3 in regulating thymus and parathyroid differentiation and morphogenesis in mouse.	HOXA3 KRT8 TBX1	1.91e-05	19	96	3	25249461
Pubmed	Transgenerational epigenetic effects imposed by neonicotinoid thiacloprid exposure.	HOXA3 NANOGP8 NANOG STK31	2.06e-05	58	96	4	37973188
Pubmed	Vertebrates have conserved capping protein alpha isoforms with specific expression patterns.	CAPZA1 CAPZA2	2.26e-05	3	96	2	9331217
Pubmed	Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.	NANOGP8 NANOG	2.26e-05	3	96	2	19447925
Pubmed	Elk3 deficiency causes transient impairment in post-natal retinal vascular development and formation of tortuous arteries in adult murine retinae.	ELK1 ELK3	2.26e-05	3	96	2	25203538
Pubmed	The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1.	NANOGP8 NANOG	2.26e-05	3	96	2	30814124
Pubmed	The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	30846691
Pubmed	Generation of germline-competent induced pluripotent stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	17554338
Pubmed	Multiple phases in regulation of Nanog expression during pre-implantation development.	NANOGP8 NANOG	2.26e-05	3	96	2	26660234
Pubmed	Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog.	NANOGP8 NANOG	2.26e-05	3	96	2	18177668
Pubmed	Expression of Nanog gene promotes NIH3T3 cell proliferation.	NANOGP8 NANOG	2.26e-05	3	96	2	16259959
Pubmed	Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19.	KRT8 DMD	2.26e-05	3	96	2	16000376
Pubmed	A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	12609610
Pubmed	Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1.	NANOGP8 NANOG	2.26e-05	3	96	2	24227785
Pubmed	Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast.	NANOGP8 NANOG	2.26e-05	3	96	2	24929238
Pubmed	Nanog and transcriptional networks in embryonic stem cell pluripotency.	NANOGP8 NANOG	2.26e-05	3	96	2	17211451
Pubmed	The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis.	NANOGP8 NANOG	2.26e-05	3	96	2	23770853
Pubmed	The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.	NANOGP8 NANOG	2.26e-05	3	96	2	15502159
Pubmed	CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation.	CSNK1A1L CSNK1A1	2.26e-05	3	96	2	28878021
Pubmed	Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice.	BIRC2 DMD	2.26e-05	3	96	2	23184147
Pubmed	Nanog variability and pluripotency regulation of embryonic stem cells--insights from a mathematical model analysis.	NANOGP8 NANOG	2.26e-05	3	96	2	20574542
Pubmed	lincRNAs act in the circuitry controlling pluripotency and differentiation.	NANOGP8 NANOG	2.26e-05	3	96	2	21874018
Pubmed	Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations.	NANOGP8 NANOG	2.26e-05	3	96	2	23054952
Pubmed	Nanog-independent reprogramming to iPSCs with canonical factors.	NANOGP8 NANOG	2.26e-05	3	96	2	24527385
Pubmed	Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.	CSNK1A1L CSNK1A1	2.26e-05	3	96	2	26811327
Pubmed	Aromatic residues in the C-terminal domain 2 are required for Nanog to mediate LIF-independent self-renewal of mouse embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	18086680
Pubmed	Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.	TLX3 TLX1	2.26e-05	3	96	2	22366949
Pubmed	Net, a new ets transcription factor that is activated by Ras.	ELK1 ELK3	2.26e-05	3	96	2	7958835
Pubmed	Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	17204467
Pubmed	CrxOS maintains the self-renewal capacity of murine embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	19800316
Pubmed	Chromatin decondensation and nuclear softening accompany Nanog downregulation in embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	23200040
Pubmed	Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog.	NANOGP8 NANOG	2.26e-05	3	96	2	26975336
Pubmed	Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3.	NANOGP8 NANOG	2.26e-05	3	96	2	23329853
Pubmed	NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers.	NANOGP8 NANOG	2.26e-05	3	96	2	26751055
Pubmed	Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	17352742
Pubmed	Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.	CSNK1A1L CSNK1A1	2.26e-05	3	96	2	19805514
Pubmed	Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.	TLX3 TLX1	2.26e-05	3	96	2	14504110
Pubmed	OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells.	NANOGP8 NANOG	2.26e-05	3	96	2	23178592
Pubmed	Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency.	NANOGP8 NANOG	2.26e-05	3	96	2	25005472
Pubmed	Roles of the Nanog protein in murine F9 embryonal carcinoma cells and their endoderm-differentiated counterparts.	NANOGP8 NANOG	2.26e-05	3	96	2	16773043
Pubmed	Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming.	NANOGP8 NANOG	2.26e-05	3	96	2	23665121
Pubmed	Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts.	NANOGP8 NANOG	2.26e-05	3	96	2	26733157
Pubmed	mNanog possesses dorsal mesoderm-inducing ability by modulating both BMP and Activin/nodal signaling in Xenopus ectodermal cells.	NANOGP8 NANOG	2.26e-05	3	96	2	23071603
Pubmed	Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features.	NANOGP8 NANOG	2.26e-05	3	96	2	16501172
Pubmed	Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	19582141
Pubmed	NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis.	NANOGP8 NANOG	2.26e-05	3	96	2	21119109
Pubmed	Pluripotency factor NANOG promotes germ cell maintenance in vitro without triggering dedifferentiation of spermatogonial stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	32145514
Pubmed	Nanog is the gateway to the pluripotent ground state.	NANOGP8 NANOG	2.26e-05	3	96	2	19703398
Pubmed	Nanog safeguards pluripotency and mediates germline development.	NANOGP8 NANOG	2.26e-05	3	96	2	18097409
Pubmed	Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology.	NANOGP8 NANOG	2.26e-05	3	96	2	28636920
Pubmed	Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst.	NANOGP8 NANOG	2.26e-05	3	96	2	25753417
Pubmed	Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.	CAPZA1 CAPZA2	2.26e-05	3	96	2	12470955
Pubmed	Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia.	CSNK1A1L CSNK1A1	2.26e-05	3	96	2	24616378
Pubmed	A distinct expression pattern in mammalian testes indicates a conserved role for NANOG in spermatogenesis.	NANOGP8 NANOG	2.26e-05	3	96	2	20539761
Pubmed	Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.	NANOGP8 NANOG	2.26e-05	3	96	2	18584034
Pubmed	Adhesion regulates MAP kinase/ternary complex factor exchange to control a proliferative transcriptional switch.	ELK1 ELK3	2.26e-05	3	96	2	23063436
Pubmed	Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells.	NANOGP8 NANOG	2.26e-05	3	96	2	21969378
Pubmed	The phosphoinositide-3-kinase/Akt pathway mediates the transient increase in Nanog expression during differentiation of F9 cells.	NANOGP8 NANOG	2.26e-05	3	96	2	20661723
Pubmed	NANOG restores the impaired myogenic differentiation potential of skeletal myoblasts after multiple population doublings.	NANOGP8 NANOG	2.26e-05	3	96	2	29245050
Pubmed	Capping protein regulates endosomal trafficking by controlling F-actin density around endocytic vesicles and recruiting RAB5 effectors.	CAPZA1 CAPZA2	2.26e-05	3	96	2	34796874
Pubmed	Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.	NANOGP8 NANOG	2.26e-05	3	96	2	22337995
Pubmed	A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.	TLX3 TLX1	2.26e-05	3	96	2	11587205
Interaction	DGKZ interactions	CEBPZ RBL2 CAPZA1 ZFC3H1 DMD ZRANB1	5.38e-06	99	90	6	int:DGKZ
Interaction	NINL interactions	KRT8 ODF2L CSNK1A1 CEP290 ITSN2 CAPZA1 CAPZA2 ZFC3H1 CCDC77 TXLNG DNAH1	6.13e-06	458	90	11	int:NINL
Interaction	KDM2B interactions	NANOG TLX3 ELK3 BCOR ECPAS ZRANB1 TLX1	7.81e-06	161	90	7	int:KDM2B
Cytoband	12q21.32	TMTC3 CEP290	1.20e-04	8	96	2	12q21.32
GeneFamily	NKL subclass homeoboxes and pseudogenes	NANOGP8 NANOG TLX3 TLX1	7.67e-05	67	61	4	519
GeneFamily	ETS transcription factor family	EHF ELK1 ELK3	1.13e-04	28	61	3	534
GeneFamily	EF-hand domain containing	MICU3 ITSN2 PPEF2 EFHB DNAH7	8.54e-04	219	61	5	863
GeneFamily	Dyneins, axonemal	DNAH7 DNAH1	1.47e-03	17	61	2	536
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	IFT172 CEP290	2.26e-03	21	61	2	980
GeneFamily	Keratins, type II	KRT8 KRT82	3.72e-03	27	61	2	609
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ODF2L EHF CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1 LRRC9	4.78e-10	200	95	9	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ODF2L EHF CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1 LRRC9	4.78e-10	200	95	9	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PLEKHG7 CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1 LRRC9	1.16e-08	200	95	8	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1 LRRC9	4.12e-08	154	95	7	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1 LRRC9	4.12e-08	154	95	7	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1 LRRC9	4.31e-08	155	95	7	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1 LRRC9	4.31e-08	155	95	7	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ODF2L PLEKHG7 DZIP3 DLEC1 EFHB ANKFN1 DNAH7	7.79e-08	169	95	7	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A8 ATR EHF BIRC2 DLEC1 ZFC3H1 TRIM7	9.51e-08	174	95	7	7be0c6248e77f2d0260b852b01e17892f7828f1b
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC4A8 ATR EHF BIRC2 DLEC1 ZFC3H1 TRIM7	9.89e-08	175	95	7	1b910c08d2bfbcc77431ee66103e63a11a9d39fe
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C1orf232 SLC4A8 CFAP45 TRIM31 DLEC1 DNAH7 DNAH1	1.11e-07	178	95	7	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C1orf232 ODF2L DLEC1 EFHB ANKFN1 DNAH7 DNAH1	1.20e-07	180	95	7	92fb01b91261b3103454924cde56add337b41844
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	PLEKHG7 CFAP45 DLEC1 ANKFN1 DNAH7 DNAH1 LRRC9	2.29e-07	198	95	7	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLC4A8 CFAP45 DLEC1 EFHB ANKFN1 DNAH7 DNAH1	2.45e-07	200	95	7	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG7 DLEC1 ANKFN1 DNAH7 DNAH1 LRRC9	9.86e-07	154	95	6	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG7 DLEC1 ANKFN1 DNAH7 DNAH1 LRRC9	9.86e-07	154	95	6	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GGH CSNK1A1L CEBPZ FXN BCOR DNAH7	1.47e-06	165	95	6	436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GGH CSNK1A1L CEBPZ FXN BCOR DNAH7	1.47e-06	165	95	6	242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EHF CFAP45 DLEC1 DNAH7 TBX1 LRRC9	1.47e-06	165	95	6	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EHF CFAP45 DLEC1 DNAH7 TBX1 LRRC9	1.47e-06	165	95	6	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG7 CFAP45 DLEC1 UNC5D TBX1 DNAH1	1.64e-06	168	95	6	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	PLEKHG7 CFAP45 DZIP3 DLEC1 EFHB DNAH7	2.86e-06	185	95	6	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	PLEKHG7 CFAP45 DLEC1 EFHB ANKFN1 DNAH7	3.14e-06	188	95	6	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	ASK452-Epithelial-Ciliated\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	ODF2L EHF CFAP45 DZIP3 EFHB DNAH7	3.65e-06	193	95	6	c0d10075862ac878aa05fc49c8b73e470783bf16
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG7 CFAP45 DZIP3 EFHB ANKFN1 DNAH7	3.76e-06	194	95	6	3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG7 CFAP45 DZIP3 DLEC1 EFHB DNAH7	3.87e-06	195	95	6	79dc031258579ea328181dda33710dd897f1064a
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	CFAP45 DLEC1 EFHB DNAH7 DNAH1 LRRC9	3.87e-06	195	95	6	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CFAP45 DZIP3 DLEC1 EFHB DNAH7	4.11e-06	197	95	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CFAP45 DZIP3 DLEC1 EFHB DNAH7	4.11e-06	197	95	6	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ODF2L CEP290 DLEC1 DMD DNAH7 LRRC9	4.11e-06	197	95	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CFAP45 DZIP3 DLEC1 EFHB DNAH7	4.11e-06	197	95	6	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CFAP45 DZIP3 DLEC1 EFHB DNAH7	4.11e-06	197	95	6	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC4A8 CFAP45 DLEC1 EFHB DNAH7 DNAH1	4.35e-06	199	95	6	15f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	IFT172 CFAP45 DZIP3 DLEC1 EFHB DNAH7	4.48e-06	200	95	6	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG7 CFAP45 DLEC1 EFHB ANKFN1 DNAH7	4.48e-06	200	95	6	926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG7 CFAP45 DLEC1 EFHB ANKFN1 DNAH7	4.48e-06	200	95	6	06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KANSL3 HOXB3 MICU3 STON1 TP53TG5 PACSIN2	4.48e-06	200	95	6	a372ef3f9e6ff6e3c3376d6e10182977c5067788
ToppCell	droplet-Heart-HEART-1m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ODF2L ST3GAL5 HSPA4L NOL10 PFKFB4	7.83e-06	127	95	5	983489a69d3b1f1fe21110a862ac1dba53e9d31c
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP45 DLEC1 ANKFN1 DNAH7 LRRC9	1.64e-05	148	95	5	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP45 DLEC1 ANKFN1 DNAH7 LRRC9	1.64e-05	148	95	5	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLEC1 EFHB ANKFN1 DNAH1 LRRC9	1.81e-05	151	95	5	81cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLEC1 EFHB ANKFN1 DNAH1 LRRC9	1.81e-05	151	95	5	9cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 ATR CFAP45 TBC1D22B TBX1	2.18e-05	157	95	5	a426c54fd1545093d41426e9620862f71bd06f6b
ToppCell	droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ODF2L CD247 HSPA4L CFAP45 TLX1	2.94e-05	167	95	5	a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCell	Ciliated_cells-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	ODF2L CFAP45 DZIP3 EFHB DNAH7	3.38e-05	172	95	5	187ae91148d293537afc77e10da2b64302322224
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG7 CFAP45 DLEC1 EFHB DNAH7	3.47e-05	173	95	5	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA3 KRT8 PLEKHG7 IFT172 AVIL	3.98e-05	178	95	5	f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GGH PLBD1 KRT8 EHF TRIM31	4.31e-05	181	95	5	4d7d367f4ed390908888391335c714a22b5a75c4
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLEKHG7 CFAP45 DLEC1 ANKFN1 DNAH7	4.31e-05	181	95	5	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	E17.5-Epithelial-airway_epithelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KRT8 HSPA4L EHF CFAP45 TBX1	4.54e-05	183	95	5	07cebb0e186e1bff14ac2a6bb6f8412d4aaa2350
ToppCell	E17.5-Epithelial-airway_epithelial_cell-club_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KRT8 HSPA4L EHF CFAP45 TBX1	4.54e-05	183	95	5	e8e85e5be909f9cd85a6a041190bfcb855dfa1a4
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA3 KRT8 IFT172 AVIL EHF	4.78e-05	185	95	5	686ed7550c6acd18e71e0076936ec5b07389adbd
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	PLEKHG7 CFAP45 DLEC1 ANKFN1 DNAH7	4.78e-05	185	95	5	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP45 DZIP3 DLEC1 EFHB DNAH7	4.91e-05	186	95	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP45 DLEC1 EFHB ANKFN1 DNAH7	4.91e-05	186	95	5	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLEKHG7 CFAP45 DLEC1 ANKFN1 DNAH7	5.03e-05	187	95	5	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP45 DLEC1 EFHB ANKFN1 DNAH7	5.16e-05	188	95	5	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLEKHG7 CFAP45 DLEC1 ANKFN1 DNAH7	5.29e-05	189	95	5	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP45 DLEC1 EFHB ANKFN1 DNAH7	5.29e-05	189	95	5	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	PLEKHG7 CFAP45 DLEC1 ANKFN1 DNAH7	5.29e-05	189	95	5	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	PLEKHG7 CFAP45 DLEC1 ANKFN1 DNAH7	5.29e-05	189	95	5	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	CFAP45 DZIP3 DLEC1 EFHB DNAH7	5.43e-05	190	95	5	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KRT8 ST3GAL5 EHF DMD TBX1	5.56e-05	191	95	5	63aa671837b79d2feb7ed1e67712cc01caf72bef
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-Tuft-related\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA3 KRT8 IFT172 AVIL EHF	5.70e-05	192	95	5	d6ea34391c3f730684b82e912d9cf55e928b3311
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL28A1 CFAP45 DLEC1 EFHB DNAH7	5.99e-05	194	95	5	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	ASK440-Epithelial-Ciliated\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	ODF2L CFAP45 DZIP3 EFHB DNAH7	5.99e-05	194	95	5	c84a7fa94fb06e08aae04db56c8c313b0afde1d7
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP45 DLEC1 EFHB ANKFN1 DNAH7	5.99e-05	194	95	5	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	PCW_13-14-Epithelial-Epithelial_airway\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KRT8 ST3GAL5 EHF DMD TBX1	5.99e-05	194	95	5	7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL28A1 DZIP3 DLEC1 EFHB DNAH7	5.99e-05	194	95	5	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CFAP45 DZIP3 EFHB DNAH7	5.99e-05	194	95	5	a46238514bca920c3e3713d23c18ba24a09e2a29
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG7 CFAP45 DZIP3 EFHB DNAH7	6.14e-05	195	95	5	db4270c135c392ed443670981656e3cd5b95939d
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP45 DZIP3 DLEC1 EFHB DNAH7	6.14e-05	195	95	5	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG7 CFAP45 DZIP3 EFHB DNAH7	6.14e-05	195	95	5	6365e3893e38231090ec2dbef010dec71dea3d07
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MORC1 CD247 ZBED4 KLRF2 DZIP3	6.29e-05	196	95	5	1cc2b11764584129703ec61965e8ec4e051464e7
ToppCell	cellseq-Epithelial-Epithelial_Airway\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KRT8 HSPA4L IFT172 EHF TRIM7	6.29e-05	196	95	5	faa39c567f24403e511b240c1d1a654ffadd8473
ToppCell	NS-critical-d_0-4-Epithelial-Ciliated-diff\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KRT8 CFAP45 DZIP3 EFHB DNAH7	6.44e-05	197	95	5	62e20ef825b92908d7732aa625dcff7b95ef6ca8
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP45 DLEC1 EFHB DNAH7 DNAH1	6.44e-05	197	95	5	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT172 CFAP45 DZIP3 EFHB DNAH7	6.44e-05	197	95	5	d83c61d2b5742e463122e1a98c7197a5b5b3d41b
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP45 DZIP3 DLEC1 EFHB DNAH7	6.44e-05	197	95	5	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	EHF CFAP45 DLEC1 DNAH7 DNAH1	6.60e-05	198	95	5	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	EHF CFAP45 DLEC1 DNAH7 DNAH1	6.60e-05	198	95	5	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	LPS_only-Epithelial_airway-airway_epithelial\|LPS_only / Treatment groups by lineage, cell group, cell type	ODF2L EHF ANKFN1 DNAH7 DNAH1	6.60e-05	198	95	5	e035380578c01b0243bfef29ca9b50cc17cce771
ToppCell	LPS_only-Epithelial_airway\|LPS_only / Treatment groups by lineage, cell group, cell type	ODF2L EHF ANKFN1 DNAH7 DNAH1	6.60e-05	198	95	5	ba090210392e001a3f7bdf09371b3f0e0c8c7ef3
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT8 PLEKHG7 EHF CFAP45 DNAH7	6.75e-05	199	95	5	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT8 PLEKHG7 EHF CFAP45 DNAH7	6.75e-05	199	95	5	74087b4b5e567310fc4ac58fb267ff651a180680
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ODF2L CFAP45 DLEC1 DNAH7 DNAH1	6.75e-05	199	95	5	60919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCell	Caecum-(5)_Dendritic_cell-(51)_cDC1\|Caecum / shred on region, Cell_type, and subtype	HOXA3 PLBD1 EHF ARHGAP20 INPP5J	6.75e-05	199	95	5	2b97fda45241b2ce7be904cf081cabcf3eb5ba1d
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ODF2L EHF CFAP45 CRISP3 LRRC9	6.75e-05	199	95	5	8649c2380285a668782d75eb076ce548eed0911d
ToppCell	distal-Epithelial-Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IFT172 CFAP45 DLEC1 EFHB DNAH7	6.75e-05	199	95	5	6ce0df4a6f4d9353919e26ffab97c9ec89911da6
ToppCell	Caecum-Dendritic_cell-cDC1\|Caecum / Region, Cell class and subclass	HOXA3 PLBD1 EHF ARHGAP20 INPP5J	6.75e-05	199	95	5	9ab38a0060a883de6fe3da8cdac42e124d7981d9
ToppCell	LPS_anti-TNF-Epithelial_airway\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ODF2L CFAP45 DLEC1 DNAH7 DNAH1	6.75e-05	199	95	5	6aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCell	(10)_Ciliated\|World / shred by cell type by condition	CFAP45 DZIP3 DLEC1 EFHB DNAH7	6.92e-05	200	95	5	1b6a8025bd2746b626040058c122b1be3ab2fa61
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP45 DLEC1 EFHB ANKFN1 DNAH7	6.92e-05	200	95	5	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ODF2L SLC4A8 EHF DLEC1 DNAH7	6.92e-05	200	95	5	cf191104484bfb2b9f87de416b9453135f8833c1
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP45 DLEC1 ANKFN1 DNAH7 DNAH1	6.92e-05	200	95	5	31d75c26055177d656df1fbb10b764cebd61e122
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP45 DLEC1 EFHB ANKFN1 DNAH7	6.92e-05	200	95	5	85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCell	Biopsy_IPF-Epithelial-Ciliated\|Biopsy_IPF / Sample group, Lineage and Cell type	IFT172 CFAP45 DZIP3 DLEC1 DNAH7	6.92e-05	200	95	5	bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8
ToppCell	LPS_IL1RA-Epithelial_airway\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ODF2L SLC4A8 EHF DLEC1 DNAH7	6.92e-05	200	95	5	a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607
ToppCell	(09)_Interm._secr.>cil.\|World / shred by cell type by condition	CFAP45 DZIP3 DLEC1 EFHB DNAH7	6.92e-05	200	95	5	3305e14dba12e94da42f0414fdc7a2c8caf0a183
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP45 DLEC1 ANKFN1 DNAH7 DNAH1	6.92e-05	200	95	5	e1dce91c6c531bb212002a14705e496d77ad3490
Disease	colon cancer (implicated_via_orthology)	NANOGP8 ATR NANOG	5.07e-06	11	94	3	DOID:219 (implicated_via_orthology)
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1A1L CSNK1A1	2.09e-04	7	94	2	DOID:0060807 (implicated_via_orthology)
Disease	Embryonal Rhabdomyosarcoma	DMD BCOR	2.78e-04	8	94	2	C0206656
Disease	cystic kidney disease (implicated_via_orthology)	IFT172 CEP290	4.44e-04	10	94	2	DOID:2975 (implicated_via_orthology)
Disease	Bardet-Biedl Syndrome	IFT172 CEP290	7.65e-04	13	94	2	C0752166
Disease	DiGeorge syndrome (implicated_via_orthology)	HOXA3 TBX1	1.66e-03	19	94	2	DOID:11198 (implicated_via_orthology)
Disease	Severe Combined Immunodeficiency	CD247 TBX1	1.84e-03	20	94	2	C0085110
Disease	airway responsiveness measurement	DZIP3 ANKFN1	2.65e-03	24	94	2	EFO_0006897
Disease	hypertension	HOXA3 HOXB3 STON1 CAPZA1 HECTD4	3.05e-03	307	94	5	EFO_0000537
Disease	Uterine leiomyoma	ZEB1 STON1 PLEKHM3	3.11e-03	91	94	3	HP_0000131

Protein segments in the cluster

Peptide	Gene	Start	Entry
NNLMKLVQKFGTEWA	PPP2R1B	476	P30154
SAMFKQLFQKWSVKD	AVIL	336	O75366
QLFQKWSVKDQTMGL	AVIL	341	O75366
WGLRKNKTNMNYDKL	ELK1	46	P19419
WNKILSYKIGKEMQN	CAPZA1	271	P52907
TKKWSLNDLQMIDGK	EXOC1L	66	A0A1B0GW35
NQNKEKSWMLEKDNL	CCDC77	296	Q9BR77
MNQAFWKTYKSKVLQ	C1orf232	1	A0A0U1RR37
NMNFKWSELRKKSLN	DMD	2781	P11532
NGKSMSLKNKALDWA	BCOR	521	Q6W2J9
ETKIAKWNLQSRMNK	ODF2L	211	Q9ULJ1
NWKELIMSNTKLLKA	ITSN2	1256	Q9NZM3
QKSVSDMIKEFRKNW	PARPBP	6	Q9NWS1
FLEQQNKMLETKWSL	KRT8	111	P05787
NKMLETKWSLLQQQK	KRT8	116	P05787
LKWASFSNNNLTKME	LRRC9	911	Q6ZRR7
LKNAQAASWEMKRKQ	MORC1	691	Q86VD1
SEQSLIEFFNKMKKW	RBL2	121	Q08999
WNVKKQSVYLMNLRK	FXN	66	Q16595
RNWDMKAALQKLFSK	OR1A2	291	Q9Y585
FPWMKESRQNTKQKT	HOXA3	156	O43365
SKKSQKWDEMNILAT	PPP1R2P1	41	Q96PQ5
LQSVKQYWKQADKIM	DDX60L	911	Q5H9U9
QKEMVWNNNKKLSDL	CFAP45	151	Q9UL16
ITQKALQSQSWKMKA	ECPAS	1531	Q5VYK3
QRWEGFQQKLMSKKN	CSTL1	26	Q9H114
DQNIKDLKVWTSQMK	PFKFB4	291	Q16877
QEIMEKYNIKLKWTN	CFHR2	211	P36980
MSKQSLQVLKKCWAF	HERC6	511	Q8IVU3
YKQVKTWFQNQRMKS	NANOG	136	Q9H9S0
LEQKNKLLETKWNFM	KRT82	141	Q9NSB4
KTWKSLSKQELNQML	MICU3	181	Q86XE3
FDWTMLKQKAAQQAA	CSNK1A1L	296	Q8N752
KMWNKNSGKIFTSLE	NOL10	296	Q9BSC4
QKKQKSFWQRLNMDE	PLEKHM3	731	Q6ZWE6
KQKVATMAWAAFQVL	HECTD4	1316	Q9Y4D8
KNLKEQLSMKRSQWE	DZIP3	821	Q86Y13
SKKSQKWDEMNILAT	PPP1R2	41	P41236
QDFMEKQDKWTRKNI	PLBD1	136	Q6P4A8
AANKDNWNKFLMAIK	IFT172	1706	Q9UG01
KASLMNDDFEKIKNW	PACSIN2	101	Q9UNF0
PQSQANKWIKNMEKD	DNAH1	3236	Q9P2D7
MNQKSILWSALKQKA	ATR	456	Q13535
IDLKFWHKKMDFSQN	KLRF2	51	D3W0D1
WKDLQTFKQKVKSMN	COL28A1	111	Q2UY09
LKMEWNKEAAANAQK	CRISP3	61	P54108
KWSLSVKNFTMNEKL	GGH	196	Q92820
LNKFKQTAWDLMKQS	CEP290	1596	O15078
MKWKALFTAAILQAQ	CD247	1	P20963
TLKWKIFTNFKMNIL	CCR8	191	P51685
AQLWGKKKNNSSMTY	EHF	246	Q9NZC4
QANKWIKNMEKANSL	DNAH7	2996	Q8WXX0
AFDMLWKLQKQKTSL	FASTKD1	71	Q53R41
PWMKESRQTSKLKNN	HOXB3	131	P14651
VAKLWGLRKNKTNMN	ELK3	41	P41970
EFANFLNWKDKMLLK	EFHB	621	Q8N7U6
GWTMAQNKLFNKILK	KANSL3	131	Q9P2N6
WKNKDITMQSTKQYA	FBXL5	431	Q9UKA1
ESNLKTKLKAMWQGE	CCDC168	2421	Q8NDH2
VKSFVMNFKNNNSKW	DCBLD1	341	Q8N8Z6
MNFKNNNSKWKTYKG	DCBLD1	346	Q8N8Z6
QSFDKEWVAKQTKRM	COX4I1	131	P13073
IGINVKKAFKMWNNS	DLEC1	771	Q9Y238
AMANKDNASLKQLRW	CEBPZ	1001	Q03701
NMLEYKSWLKNLAKE	PPEF2	621	O14830
NNFKIKNKIKLTDMW	ARHGAP20	121	Q9P2F6
NRFFKSMNKNDMKSW	TRIM31	306	Q9BZY9
SMNKNDMKSWGLLQK	TRIM31	311	Q9BZY9
MAAENSKQFWKRSAK	TBC1D22B	1	Q9NU19
YKQVKTWFQNQRMKS	NANOGP8	136	Q6NSW7
FDWTMLKQKAAQQAA	CSNK1A1	296	P48729
NTFFKSQNWEMAIKK	PPID	231	Q08752
FKSVDFNWLQAMVKK	ST3GAL5	266	Q9UNP4
QALLQSEKMLWQFLK	SEC31B	456	Q9NQW1
WKALSMNSGNAKEKS	SLC4A8	1076	Q2Y0W8
TILSDWTNSNKQKMK	BIRC2	26	Q13490
WNKILSYKIGKEMQN	CAPZA2	271	P47755
NGKWMQISKLQSQRK	ANKFN1	561	Q8N957
YKEWKSQVQSGMRNK	TP53TG5	126	Q9Y2B4
KDQLNMAKNTWPILK	INPP5J	631	Q15735
TFWAQSINRNKDIMK	STK31	46	Q9BXU1
KSKQKLGAFLWMQRN	TCEAL4	171	Q96EI5
EMKNKVWNVSLKTFV	TRIM7	306	Q9C029
KNLSFMDAMNKFKWT	MOXD1	516	Q6UVY6
QLRKEQTKLKWMQSE	MIX23	101	Q4VC31
ALWTMNLQRQKSLKA	STON1	581	Q9Y6Q2
SWLNSKMNAQNKLSL	HSPA4L	746	O95757
KGKDWQMLAQKNSIN	UNC5D	871	Q6UXZ4
KSLKMTDAQVKTWFQ	TLX3	201	O43711
KKWFEKMQAGQISVQ	ZEB1	626	P37275
KALKMTDAQVKTWFQ	TLX1	236	P31314
FLLQAQTENIKKTWM	PLEKHG7	646	Q6ZR37
SMQKSVQNKIKSLNW	PSMG2	146	Q969U7
AKGAQWMKQIVSFDK	TBX1	201	O43435
WMKQIVSFDKLKLTN	TBX1	206	O43435
MSALKVNKNNAKLWN	TMTC3	436	Q6ZXV5
TKWENNNKALLQMAE	TXLNG	401	Q9NUQ3
SASKKWQQKEQQVMK	ZFC3H1	381	O60293
KNRMKKTDWLFLNAC	ZRANB1	256	Q9UGI0
VMFPVNSKKTSKLWN	ZBED4	551	O75132
WLQVASMNQKRSNFK	KLHL42	281	Q9P2K6